Affiliation:
1. State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou 510060 China
2. School of Pharmacy Guangdong Pharmaceutical University Guangzhou 510006 China
3. Department of Hepatobiliary Oncology Sun Yat‐sen University Cancer Center Guangzhou 510060 China
Abstract
AbstractPancreatic cancer renders a principal cause of cancer mortalities with a dismal prognosis, lacking sufficiently safe and effective therapeutics. Here, diversified cyclodiaryliodonium (CDAI) NADPH oxidase (NOX) inhibitors are rationally designed with tens of nanomolar optimal growth inhibition, and CD44‐targeted delivery is implemented using synthesized sulfated glycosaminoglycan derivatives. The self‐assembled nanoparticle‐drug conjugate (NDC) enables hyaluronidase‐activatable controlled release and facilitates cellular trafficking. NOX inhibition reprograms the metabolic phenotype by simultaneously impairing mitochondrial respiration and glycolysis. Moreover, the NDC selectively diminishes non‐mitochondrial reactive oxygen species (ROS) but significantly elevates cytotoxic ROS through mitochondrial membrane depolarization. Transcriptomic profiling reveals perturbed p53, NF‐κB, and GnRH signaling pathways interconnected with NOX inhibition. After being validated in patient‐derived pancreatic cancer cells, the anticancer efficacy is further verified in xenograft mice bearing heterotopic and orthotopic pancreatic tumors, with extended survival and ameliorated systemic toxicity. It is envisaged that the translation of cyclodiaryliodonium inhibitors with an optimized molecular design can be expedited by enzyme‐activatable targeted delivery with improved pharmacokinetic profiles and preserved efficacy.
Funder
Natural Science Foundation of Guangdong Province
National Natural Science Foundation of China
National Key Research and Development Program of China
Subject
Pharmaceutical Science,Biomedical Engineering,Biomaterials
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献